Transsacral exenteration of fixed primary and recurrent anorectal cancer

Am J Surg. 2003 Dec;186(6):670-4. doi: 10.1016/j.amjsurg.2003.08.020.

Abstract

Background: Posteriorly fixed anorectal cancer is often considered incurable, but may be resectable using transsacral approaches.

Methods: We reviewed 45 patients undergoing transsacral exenteration for this problem since 1983 to determine outcome of such surgery.

Results: The group consisted of 38 men and 7 women; 17 had primary tumors, 28 had recurrent cancer: local excision, 1; low anterior resection, 11; or abdominoperineal resection, 16. Thirty-nine had prior XRT. Operative mortality was 4%. Severe pain was relieved in 16 of 22 (72%) patients. Crude recurrence rates are local 22%, local plus distant 11%, distant 16%. Five-year disease-free survival is 31% for primary disease, 32% for recurrence. Median survival is abdominoperineal resection recurrence, 24 months; primary cancer, 30 months; low anterior resection recurrence, 37 months.

Conclusions: Transsacral exenteration relieved pain in 70% of patients with fixed anorectal cancer, and led to long-term survival in 31% to 32%. Prognosis trended toward benefit for recurrence after low anterior resection.

MeSH terms

  • Adult
  • Aged
  • Anus Neoplasms / mortality
  • Anus Neoplasms / surgery
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pelvic Exenteration / adverse effects
  • Pelvic Exenteration / methods*
  • Postoperative Complications
  • Rectal Neoplasms / mortality
  • Rectal Neoplasms / surgery*
  • Survival Rate